| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
4 companies
Berger Franklin M is a Director at KZR, with reported holdings spanning 4 companies. Recent filings cover 10 purchases and 3 sales. Those positions are worth an estimated $13.4M at current prices.
Our model assigns Berger Franklin M a middling insider score of 52/100, based on 7 past trades. Over a 12-month horizon, 57.1% of those trades were profitable, with an average 12-month return of -9.7%.
Berger Franklin M's largest disclosed position is in KZR as Director, worth about $13.2M. Net of sales, the recent Form 4 record there shows accumulation of 350,846 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 13, 2026 | RTSN Retension Pharmaceuticals, Inc. | Director | Buy | 10,000 | $12.00 | $120,000.00 | New | - | - | |
| Jan 16, 2025 | AVIR Atea Pharmaceuticals, Inc. | Director | Buy | 25,000 | $3.26 | $81,498.50 | +5.5% | -9.9% | +2.1% | |
| Dec 10, 2024 | AVIR Atea Pharmaceuticals, Inc. | Director | Sell | 359,606 | $2.85 | $1,023,474.64 | -44.3% | -0.7% | +7.5% | |
| Nov 14, 2022 | AVIR Atea Pharmaceuticals, Inc. | Director | Sell | 41,666 | $5.15 | $214,684.55 | -5.1% | -17.5% | -41.2% | |
| Mar 21, 2022 | KZR Kezar Life Sciences, Inc. | Director | Buy | 80,000 | $16.25 | $1,299,800.00 | +9.9% | -60.7% | -75.3% | |
| Nov 3, 2020 | AVIR Atea Pharmaceuticals, Inc. | Director | Buy | 41,666 | $24.00 | $999,984.00 | +5.4% | - | - | |
| Jun 11, 2020 | KZR Kezar Life Sciences, Inc. | Director | Buy | 100,000 | $5.50 | $550,000.00 | +14.6% | - | - | |
| Feb 4, 2020 | KZR Kezar Life Sciences, Inc. | Director | Buy | 120,846 | $2.60 | $314,199.60 | +21.5% | - | - | |
| Jun 25, 2018 | KZR Kezar Life Sciences, Inc. | Director | Buy | 50,000 | $15.00 | $750,000.00 | +9.7% | - | - |